연구동향 분석

Comprehensive Variant Screening of the UGT Gene Family

김용하 신형두 정현섭 박병래 김영효 남궁석 김지온 김해든 김영훈 정면우 한순영 2014년

논문상세정보
인용/피인용
' Comprehensive Variant Screening of the UGT Gene Family' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 의학
  • personalized medicine
  • snp
  • ugt1a1
  • ugt2b15
  • ugt2b7
  • uridinediphosphateglucuronyltransferase
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
7,762 0

0.0%

' Comprehensive Variant Screening of the UGT Gene Family' 의 참고문헌

  • Up-regulation of UDP-glucuronosyltransferase (UGT) 1A4 by 17beta-estradiol: a potential mechanism of increased lamotrigine elimination in pregnancy
    Chen H Drug Metab Dispos 37 1841-1847 [2009]
  • UGT1A1 is a major locus influencing bilirubin levels in African Americans
    Chen G Eur J Hum Genet 20 463-468 [2012]
  • UDP-glucuronosyltransferases
    King CD Curr Drug Metab 1 143-161 [2000]
  • UDP-glucuronosyltransferase (UGT) 2B15 pharmacogenetics: UGT2B15 D85Y genotype and gender are major determinants of oxazepam glucuronidation by human liver
    Court MH J Pharmacol Exp Ther 310 656-665 [2004]
  • Therapeutic inhibition of Sp1 expression in growing tumors by mithramycin a correlates directly with potent antiangiogenic effects on human pancreatic cancer
    Yuan P Cancer 110 2682-2690 [2007]
  • The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert’s syndrome
    Bosma PJ N Engl J Med 333 1171-1175 [1995]
  • Substrate specificity of the human UDP-glucuronosyltransferase UGT2B4 and UGT2B7. Identification of a critical aromatic amino acid residue at position 33
    Barre L FEBS J 274 1256-1264 [2007]
  • Stereoselective conjugation of oxazepam by human UDP-glucuronosyltransferases (UGTs): S-oxazepam is glucuronidated by UGT2B15, while R-oxazepam is glucuronidated by UGT2B7 and UGT1A9
    Court MH Drug Metab Dispos 30 1257-1265 [2002]
  • Stable expression of a human liver UDP-glucuronosyltransferase (UGT2B15) with activity toward steroid and xenobiotic substrates
    Green MD Drug Metab Disp 22 799-805 [1994]
  • Single nucleotide polymorphisms and haplotype frequencies of UGT2B4 and UGT2B7 in a Japanese population
    Saeki M Drug Metab Dispos 32 1048-1054 [2004]
  • Regulation of UDP glucuronosyltransferases in the gastrointestinal tract
    Gregory PA Toxicol Appl Pharmacol 199 354-363 [2004]
  • RREB-1, a novel zinc finger protein, is involved in the differentiation response to Ras in human medullary thyroid carcinomas
    Thiagalingam A Mol Cell Biol 16 5335-5345 [1996]
  • Promoter length polymorphism in UGT1A1 and the risk of sporadic colorectal cancer
    Bajro MH Cancer Genet 205 163-167 [2012]
  • Probing protein stability with unnatural amino acids
    Mendel D Science 256 1798-1802 [1992]
  • Primer3 on the WWW for general users and for biologist programmers
    Rozen S Methods Mol Biol 132 365-386 [2000]
  • Preclinical prediction of factors influencing the elimination of 5,6-dimethylxanthenone-4-acetic acid, a new anticancer drug
    Miners JO Cancer Res 57 284-289 [1997]
  • Preclinical factors affecting the interindividual variability in the clearance of the investigational anti-cancer drug 5,6-dimethylxanthenone-4-acetic acid
    Zhou S Biochem Pharmacol 65 1853-1865 [2003]
  • Polymorphisms of UDP-glucuronosyltransferase gene and irinotecan toxicity: a pharmacogenetic analysis
    Ando Y Cancer Res 60 6921-6926 [2000]
  • Pharmacogenetics: from bench to byte--an update of guidelines
    Swen JJ Clin Pharmacol Ther 89 662-673 [2011]
  • Missense mutation (C1263R) in the thyroglobulin gene causes congenital goiter with mild hypothyroidism by impaired intracellular transport
    Hishinuma A Endocr J 45 315-327 [1998]
  • Isolation and characterization of UGT2B15(Y85): a UDP-glucuronosyltransferase encoded by a polymorphic gene
    Lévesque E Pharmacogenetics 7 317-325 [1997]
  • Involvement of human UGT2B7 and 2B15 in rofecoxib metabolism
    Zhang JY Drug Metab Dispos 31 652-658 [2003]
  • Induction of the transcriptional repressor ZBTB4 in prostate cancer cells by drug-induced targeting of microRNA-17-92/106b-25clusters
    Kim K Mol Cancer Ther 11 1852-1862 [2012]
  • Impact of UGT2B7 His268Tyr polymorphism on the outcome of adjuvant epirubicin treatment in breast cancer
    Parmar S Breast Cancer Res 13 R57- [2011]
  • Identification of defect in the genes for bilirubin UDP-glucuronosyl-transferase in a patient with Crigler-Najjar syndrome type II
    Aono S Biochem Biophys Res Commun 197 1239-1244 [1993]
  • Identification of a defect in the UGT1A1 gene promoter and its association with hyperbilirubinemia
    Sugatani J Biochem Biophys Res Commun 292 492-497 [2002]
  • Haploview: analysis and visualization of LD and haplotype maps
    Barrett JC Bioinformatics 21 263-265 [2005]
  • Glucuronidation of 7-ethyl-10-hydroxycamptothecin (SN-38), an active metabolite of irinotecan (CPT-11), by human UGT1A1 variants, G71R, P229Q, and Y486D
    Jinno H Drug Metab Dispos 31 108-113 [2003]
  • Glucosidation of hyodeoxycholic acid by UDP-glucuronosyltransferase 2B7
    Mackenzie P Biochem Pharmacol 65 417-421 [2003]
  • Gilbert syndrome: the UGT1A1*28 promoter polymorphism as a biomarker of multifactorial diseases and drug metabolism
    Gil J Biomark Med 6 223-230 [2012]
  • Genetic polymorphism in UDP-glucuronosyltransferase 2B7 and colorectal cancer risk
    van der Logt EM Oncol Res 17 323-329 [2009]
  • FASTSNP: an always up-to-date and extendable service for SNP function analysis and prioritization
    Yuan HY Nucleic Acids Res 34 W635-W641 [2006]
  • Effect of the UGT2B15 genotype on the pharmacokinetics, pharmacodynamics, and drug interactions of intravenous lorazepam in healthy volunteers
    Chung JY CLINICAL PHARMACOLOGY THERAPEUTICS 77 6 486-494 [2005]
  • Drug glucuronidation in clinical psychopharmacology
    Liston HL J Clin Psychopharmacol 21 500-515 [2001]
  • Common variants of four bilirubin metabolism genes and their association with serum bilirubin and coronary artery disease in Chinese Han population
    Lin R Pharmacogenet Genomics 19 310-318 [2009]
  • Common human UGT1A polymorphisms and the altered metabolism of irinotecan active metabolite 7-ethyl-10-hydroxycamptothecin (SN-38)
    Gagné JF Mol Pharmacol 62 608-617 [2002]
  • Combined effect of genetic polymorphisms in phase I and II biotransformation enzymes on head and neck cancer risk
    Lacko M Head Neck 35 858-867 [2013]
  • Biliverdin reductase: a major physiologic cytoprotectant
    Baranano DE Proc Natl Acad Sci U S A 99 16093-16098 [2002]
  • Analysis of genes for bilirubin UDP-glucuronosyltransferase in Gilbert’s syndrome
    Aono S Lancet 345 958-959 [1995]
  • An association of UDP-glucuronosyltransferase 2B7 C802T (His268Tyr) polymorphism with bladder cancer in benzidine-exposed workers in China
    Lin GF Toxicol Sci 85 502-506 [2005]
  • Amino acid substitutions in genetic variants of human serum albumin and in sequences inferred from molecular cloning
    Takahashi N Proc Natl Acad Sci U S A 84 4413-4417 [1987]
  • A novel functional polymorphism in the uridine diphosphate-glucuronosyltransferase 2B7 promoter with significant impact on promoter activity
    Duguay Y Clin Pharmacol Ther 75 223-233 [2004]
  • A comparison of linkage disequilibrium measures for fine-scale mapping
    Devlin B Genomics 29 311-322 [1995]